We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ReCap Total Hip Resurfacing Prospective Data Collection

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00758472
First Posted: September 25, 2008
Last Update Posted: June 19, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Biomet U.K. Ltd.
Information provided by (Responsible Party):
Zimmer Biomet
  Purpose
Prospective data collection on survivorship of ReCap Total Hip Resurfacing

Condition Intervention
Arthritis Device: ReCap Total Hip Resurfacing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: ReCap Total Hip Resurfacing Prospective Data Collection

Further study details as provided by Zimmer Biomet:

Primary Outcome Measures:
  • survival rate [ Time Frame: 10 yr ]

Enrollment: 82
Study Start Date: March 2005
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Hip Resurfacing Device: ReCap Total Hip Resurfacing
ReCap Total Hip Resurfacing
Other Name: RECAP

Detailed Description:
Detailed protocol not available
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suitable for Total Hip Resurfacing
Criteria

Inclusion Criteria:

  • Clinical diagnosis of hip joint arthritis

Exclusion criteria:

- less than 18 years of age

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00758472


Locations
United Kingdom
Southmead Hospital
Bristol, United Kingdom
Robert Jones & Agnes Hunt Orthopaedic & District Hospital NHS Trust
Oswestry, United Kingdom
Sponsors and Collaborators
Zimmer Biomet
Biomet U.K. Ltd.
Investigators
Principal Investigator: Evert Smith, MD North Bristol NHS Trust
  More Information

Responsible Party: Zimmer Biomet
ClinicalTrials.gov Identifier: NCT00758472     History of Changes
Other Study ID Numbers: BMET UK 08
First Submitted: September 23, 2008
First Posted: September 25, 2008
Last Update Posted: June 19, 2017
Last Verified: June 2017